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Streptomyces sp. VRY-1 was screened for its bioactive potentials against various pathogenic 
microorganisms and was found to possess antibacterial activity against Salmonella 
typhimurium  (drug resistant strain of bacteria) and various other pathogenic bacteria and 
fungi. Optimization of cultural conditions for production of antibiotic showed that maximum 
antibiotic production occurred on 10th day in stationary cultural, 28˚ C, 8.0 pH, liver extract, 
1.5%(w/v) glucose. The bioactive compound was found to be soluble in water and ethyl 
acetate. 
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Introduction 
The new drug discovery processes have proved that 
novel skeletons of drugs come from natural sources in majority 
of cases [1]. This involves the screening of microorganism and 
plant extracts [2]. Microbial production of antibiotics is one of 
the rapidly expanding branch of industrial microbiology. Biotic 
potentials of actinomycetes are very wide as are capable of 
synthesizing many different biologically active secondary 
metabolites such as antibiotics, herbicides, pesticides, 
enzymes etc. Of these compounds, antibiotics predominate in 
therapeutic and commercial importance [3, 4, 5, 6]. Antibiotics 
of actinomycetes have extremely diverse chemical structures 
as acids, bases, amphoteric compounds, neutral compounds, 
polypeptides, amino sugar complexes, compounds with huge 
lactone rings, nitro compounds, guanido compounds, polyenic 
compounds, and acetylenic compounds. The exploration of 
new habitats plays a pivotal role in search of new microbes 
possessing potentials to produce novel metabolites.  and are 
urgent to counter the threats posed by the fast emerging 
phenomenon of antibiotic resistance [7] . 
At present, resistance to the antibiotic used in the 
treatment of many infectious diseases is increasing, while 
microbial infections are being found to be responsible for more 
life threatening diseases than previously thought. The reasons 
for the increase in incidence of infectious diseases are not fully 
understood. One such reason is the emergence of multi-drug 
resistant pathogens [8].The serious infections caused by 
bacteria that have become resistant to commonly used 
antibiotics has become a major global healthcare problem in 
the 21st century [9]. Gram negative and enteric organisms 
threaten patients in hospitals and communities with multi-drug 
resistance, including broad resistance to first, second, and third 
generations of penicillin's and cephalosporin's [10, 11, 12]. 
Drug resistance develops in bacteria through several 
mechanisms. Some bacteria develop the ability to neutralize 
the antibiotic before it can do harm, others can rapidly pump 
the antibiotic out, others can change the antibiotic attack site 
so it cannot affect the function of the bacteria, some bacteria  
acquire resistance through mutation of their genetic material, 
some acquire piece of DNA that code for the resistance 
properties from other bacteria through gene transfer 
phenomenon, transfer of multi-drug resistant plasmid of one 
bacteria to other through conjugation. 
Rising numbers of antibiotic unresponsive infectious 
disease agents confront patients worldwide [13, 14]. and 
consensus has emerged that it is essential that novel antibiotic 
classes should be developed as part of the strategy to control 
the emerging drug-resistant pathogens [15,16,17]. The present 
study was carried out to evaluate the effect of antimicrobial 
compound of Streptomyces sp. VRY-1 on various pathogenic 
microbes, especially a drug resistant bacteria Salmonella 
typhimurium (MTCC 3214).          
Materials and Methods 
Streptomyces VRY-1 
The culture of Streptomyces sp. VRY-1, an isolate of 
cultivated soil was maintained on ISP-2 medium containing (g 
L-1) glucose, 4.0, malt extract, 10; yeast extract, 4.0; Agar agar, 
20. The culture was identified based on it’s cultural, 
morphological and biochemical properties using standard 
protocol [18, 19]. 
Study of antimicrobial spectrum of Streptomyces sp. VRY-
1 in a solid medium 
Culture of pathogenic microorganisms were obtained from 
Microbial Type Culture Collection and Gene Bank, IMTECH, 
Chandigarh, India for testing the antimicrobial spectrum of 
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Streptomyces VRY-1.  The cultures tested are as follow 
Salmonella typhimurium (MTCC 3214), Salmonella typhi 
(MTCC 733), Klebsiella pneumoniae (MTCC 4032), 
Streptococcus pyogenes (MTCC 1926), Staphylococcus 
aureus (MTCC 96), Candida albicans (MTCC 227), 
Microsporum gypseum (MTCC 6041), Trichophyton rubrum 
(MTCC 3272). Antimicrobial activity of the isolated 
Streptomyces sp. VRY-1 was tested using cross streak assay 
method [20, 21]. Streptomyces sp. VRY-1 was line streaked on 
the periphery of the Petri plate containing Sabouroud Dextrose 
Agar and incubated at 28±2°C for 5 days. Plates were re-
inoculated equidistantly with test pathogenic microorganisms 
by streaking at right angles to growing actinomycetes and were 
further incubated at 37°C for 24-48 hours for bacteria and at 
28°C for 4-5 days for fungi. The extent and type of inhibition 
(mm) was measured. 
Study of drug resistant spectrum of Salmonella 
typhimurium 
The drug resistance in bacteria Salmonella typhimurium 
(MTCC 3214) obtained from Microbial Type Culture Collection 
was studied against different antibiotics (10μgml-1) i.e. 
Carbenicillin, Rifampicin, Streptomycin, Tetracycline, 
Ampicillin, Kanamycin, Neomycin using agar well diffusion 
technique. The stock solutions of antibiotics were prepared in 
methanol.  The solutions of antibiotics were poured in agar well 
(8mm diameter) and allowed to diffuse in medium for 2 hours 
at 4˚C. Methanol was used as control. Suspension of S. 
typhimurium (2x10 6cells ml-1) was spread over the plates and 
inoculated at 37 ±2 °C for 24 hours. 
Production of antibiotic by Streptomyces VRY-1 
Production of antibiotic by Streptomyces sp. VRY-1 was 
done on glucose tryptone yeast extract broth. The media were 
inoculated with 2x106 cells mL-1 spores and kept for incubation 
at 28 ±2°C for 10 days. Culture broth was centrifuged at 5,000 
rpm for 15 minutes at 4°C. Supernatant was filtered through 
0.22 µm filter. The filtrate obtained was used as crude 
antibiotic sample, 100 µL of crude culture broth was poured in 
each well and allowed to diffuse. The culture of S. typhimurium 
was spread on plates and incubated at 37±2 °C for 24 hours. 
Comparison of antimicrobial spectrum of bioactive 
compound produced by Streptomyces VRY-1 with known 
antibiotics 
 Standard antibiotic solution (100 µL) of concentration 
10µg mL-1 (made in methanol) and crude culture broth of 
Streptomyces sp. VRY-1 was tested for their anti- S. 
typhimurium activity using agar wells diffuse technique.  
Optimization of culture conditions for the growth of 
Streptomyces sp. VRY-1 and antibiotic production. 
 Optimization studies were carried out in glucose tryptone 
yeast extract medium. The Streptomyces VRY-1 subjected to 
incubation period from 1-12 days, temperature  15 °C, 20 °C, 
28 °C, 37 °C and 42 °C for 10 days in stationary culture, pH- 
6, 7, 8, 9 and 10. Medium was inoculated with spore 
suspension (2x106cells mL-1) of VRY-1. Tryptone yeast extract 
medium (pH 8) having different glucose concentrations i.e., 
0.1%, 0.5%, 1.0%, 1.5% and 2.0% (w/v) was used for 
determining optimum glucose concentration for production of 
antibiotic. While for testing best nitrogen source Glucose 
tryptone yeast extract medium was supplemented with different 
nitrogen source like beef extract, malt extract, gelatin, urea, 
liver extract and peptone. In all sets of experiment the culture 
conditions were kept optimum as determined in the previous 
experiment. The optimization studies were carried out in 
triplicate set.  
Extraction of antibiotic from culture broth  
The extraction of antibiotic from crude culture broth was 
done using different solvents n-butanol, n-hexane, ethyl 
acetate, methanol and benzene. The solvents were mixed in 
1:1 proportion. Aqueous layer and organic layers were 
separated and tested for presence of antibiotic using disc 
diffusion technique.  
Thin layer chromatography and Bioautography 
The partially purified antibiotic obtained after solvent 
extraction was spotted on Silica gel plate (Sigma-Aldrich) 
eluted using solvent ethyl acetate: methanol: water (70:20:10). 
For bioautography semisolid SDA medium seeded with S. 
typhimurium culture was poured over the TLC plate and 
incubated for 2 days at 37ºC. 
Detection of plasmid in Streptomyces VRY-1  
Log phase culture of Streptomyces VRY-1 (5mL) was 
taken into Eppendorf centrifuge at 6000 rpm for 5 minutes at 
4ºC. Supernatant discarded and pellet was washed with 
sterilized Millipore water 3-4 times, 40µL of cracking buffer 
was added into the pellet and cells were crushed with the help 
of micro pestle. Sample was then loaded on 0.8 % (w/v) 
agarose gel. 
Plasmid isolation  
Plasmid isolation was carried out by using GeNei 
puresolTM plasmid isolation kit. 1.5 mL of 4-5 days old culture 
broth of Streptomyces VRY-1 was taken into Eppendorf. 
Centrifuged it at 9000 rpm for 1 minute at 4 °C. Pellet obtained 
was dissolved in 200 µL of puresol solution A and 10 µL of 
lysozyme, kept it in boiling water bath for 1 minute, 
immediately cooled it for 5 minute. Spinned down the pellet 
again at 13,000 rpm for 10 minutes at 4 °C. Supernatant 
collected and equal volume of isopropanol was added into it. 
Mixed it at room temperature for 5 minute. Again centrifuged at 
13,000 rpm for 10 minutes at 4 °C. Pellet so obtained was 
dissolved in 70% chilled ethanol and centrifuged at 8000 rpm 
for 5 minute, pellet was air dried and resuspended into 25 µL 
of puresol solution B and 2 µL of RNase. Kept it at room 
temperature for 5 minute. Run the plasmid DNA in 0.8% 
agarose gel. 
Results 
Cultural and morphological characterization  
 Spores of Streptomyces VRY-1 appeared violet on 
performing Gram’s reaction indicating culture to be Gram 
positive. The cultural and morphological characteristics are 
described in Table-1. The spore chain in VRY-1 was found to 
be less spiral. On analyzing cell wall amino acid composition it 
showed greenish spot of LL-DAP, thus we tentatively identify 
the culture to be of Streptomyces sp. 
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Table 1: Cultural and Morphological Characteristics of Streptomyces VRY-1 
S.No. Cultural & Morphological Characteristics of Streptomyces VRY-1 
1.  Appearance of colony  Powdery & wrinkled 
2.  Color of colony White 
3.  Reverse color of colony Brown 
4.  Elevation Elevated 
5.  Concentric rings Present 
6.  Diffusible Pigment Light Brown 
7.  Spore chain Spiral 
8.  Cell wall amino acid LL-DAP 
 
Primary screening 
 The culture of Streptomyces sp. VRY-1 was found to 
inhibit the growth of both Gram positive and Gram negative 
pathogenic bacteria. Also it was found to inhibit fungi Candida 
albicans and Microsporum gypseum. Indicating that organism 
Streptomyces sp. VRY-1 is producing broad spectrum of 
antimicrobial compounds. The results of antagonistic studies 
conducted are shown in Table 2. 
 
Table 2: Antagonistic Activity of Streptomyces sp. VRY-1 
S.No. Test pathogens MTCC No.      Zone of 
Inhibition( mm)** 
1. Streptococcus  pyogenes 1926 10 
2. Salmonella  typhimurium 3214 15 
3. Klebsiella  pneumoniae 4032 11 
4. Streptococcus  aureus 96 16 
5. Salmonella  typhi 733 25 
6. Bacillus sp. (Gram positive) - 15 
7. Candida albicans 227 11 
8. Microsporum  gypseum 6041 5 
9. Trichophyton rubrum 3272 No inhibition 
 
Study of drug resistant spectrum of S. typhimurium 
Among all antibiotics tested against drug resistant strain 
of S. typhimurium, kanamycin (10-40 µg/mL) and streptomycin 
(30 µg/mL  and 40 µg/mL) was able to inhibit the growth of S. 
typhimurium while other antibiotics i.e. neomycin, tetracycline, 
ampicillin, carbenicillin and rifampicin are not effective even at 
high concentration i.e. 40 µg/mL (Table 3).
 
Table 3: Effect of different antibiotics on the growth of S.typhimurium 
 
. 
 
 
 
 
 
 
 
 
 
 
 
Comparison of antimicrobial spectrum of bioactive 
compound produced by VRY-1 with known antibiotics 
 Only kanamycin was able to inhibit the growth of S. 
typhimurium at concentration of 10µg/mL and diluted as well 
as concentrated sample of VRY-1 show inhibition which was 
measured in terms of zone of inhibition in mm (Table 4).
 
Antibiotics(µg/mL) Different Concentration 
Zone of Inhibition ( mm)** 
 10 20 30 40 50 
Carbiniciline -ve -ve -ve -ve -ve 
Tetracycline -ve -ve -ve -ve -ve 
Ampiciline -ve -ve -ve -ve 4 
Neomycin -ve -ve -ve -ve 6 
Streptomycin -ve -ve 6 11 17 
Kanamycin 9 13 14 14 15 
Rifampicin -ve -ve -ve -ve -ve 
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Table 4: comparison of antimicrobial spectrum of bioactive compound produced by Streptomyces VRY-1 with known antibiotics 
S.No. Antibiotics/sample Zone of 
Inhibition (mm)** 
1 Kanamycin 9 
2 Streptomycin -ve 
3. Tetracycline -ve 
4. Ampicillin -ve 
5. Rifampicin -ve 
6. Neomycin -ve 
7. Carbenicillin -ve 
8.  sample 18 
** Excluding well diameter. 
 
Optimization of culture conditions for antibiotic 
production by Streptomyces sp. VRY-1 
Incubation period 
After every 24 hours, antibiotic activity was noticed from 
5th day of incubation which was found to increase up to 11 day 
and maximum residual activity was observed at 10th day, 
whereas it decreases from 11th day. Zone of inhibition shown in 
a Fig.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1. Effect of incubation period on growth of Streptomyces VRY-1 
and antibiotic production 
.  
Temperature 
The antibiotic production by VRY-1 was stable at different 
temperatures but growth of VRY-1 and its antibiotic production 
was more at temperature 28 °C which was shown in a Fig.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig..2: Effect of different temperature on growth of VRY-1 and 
antibiotic production 
pH 
The growth of VRY-1 was to be maximum at pH 8 but at 
pH 6 and 7 also the culture showed good growth. On 
increasing the pH to 9 the growth decreases. Maximum zone 
of inhibition i.e. 18 mm was observed at pH 8 which was 
shown in a Fig.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3: Effect of different ph on antibiotic production by Streptomyces 
VRY-1 
 
Carbon source 
At different glucose concentration, the growth and 
antibiotic production by VRY-1 varied but at 1.5% glucose 
concentration into the medium, the growth and antibiotic 
production was found more as shown in a Fig.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4: Effect of different glucose concentration on antibiotic production 
by Streptomyces VRY-1 
Nitrogen source 
Different nitrogen sources supplemented along with the 
medium composition have varying effect on growth of VRY-1 
and activity of its antibiotic, shown in Fig.5 
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Fig 5: Effect of different nitrogen source on growth of Streptomyces 
VRY-1 and antibiotic production. 
Direct concentration and ammonium sulphate 
precipitation 
Specific centrifugation 
  In order to concentratre the antibiotic present in culture 
broth two methods i.e. direct concentration and ammonium 
sulphate precipitation were used. On analyzing the sample 
(above 5 KD) the zone of inhibition against S. typhimurium 
increases, while no zone of inhibition was observed with 
ammonium sulphate precipitated sample.  
Extraction of the antibiotic from culture filtrate using 
different solvents 
The antibiotic produced by Streptomyces VRY-1 was 
subject to extraction using five solvents i.e. ethyl acetate, 
benzene, methanol, n-butanol, n-hexane. On testing 
antibacterial activity against S. typhimurium only ethyl acetate 
showed zone of inhibition, while with other solvent no inhibition 
was found, indicating that antibiotic is not soluble in pure pure 
organic solvents such as n-butanol, benzene, methanol, n-
hexane. While it is soluble in ethyl acetate. 
Thin layer chromatography 
The developed chromatogram show 4 spots whose RF 
values were calculated by the formula: 
                   RF = Distance traveled by the solute 
                          Distance traveled by the solvent 
 
Table 5 : TLC of antibiotic sample (above 5 KD) 
S. NO SPOT NO.* Rf  VALUE 
1 1 0.14 
2 2 0.25 
3 3 0.39 
4 4 0.57 
*Starting from sample loading end of TLC 
 
On performing autobiography after TLC the zone of 
inhibition was found around the third spot (Rf 0.39). It showed 
0.8 cm of zone of inhibition. 
Study of genetic material of Streptomyces VRY-1 
Detection of plasmid using cracking buffer 
Three bands each of genomic DNA, plasmid DNA and 
RNA were seen in an agarose gel (0.8%) under Gel Doc XR 
system [BIORAD]. As genomic DNA is heavier than plasmid 
DNA so its band was seen near the wells and band of plasmid 
was seen in between the bands of genomic DNA and RNA. 
Plasmid isolation 
The isolation of plasmid was carried out using GeNei 
Puresoltm plasmid isolation kit and its purity was checked using 
agarose gel (0.8%) electrophoresis. The molecular weight was 
determined to be 5148 bp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7: (i) Agarose gel showing four lanes in which lane-1 containing 
marker (λ/EcoRI + Hind III), lane-2, 3 and 4 contains  plasmid isolated 
from Streptomyces VRY-1 
Discussion 
Actinomycetes are the group of Gram positive bacteria 
having branched filaments, which somewhat resemble the 
mycelia of the fungi. Actinomycetes perform significant 
biogeochemical roles in nature and are highly valued for their 
unparallel ability to produce wide variety of biologically active 
secondary metabolites [22, 23]. The value of actinomycetes to 
society in terms of providing useful drugs for pharmaceutical 
industry is indisputable. Actinomycete products such as 
antibiotics are firmly cemented . They are chemically prolific 
bacteria in the centre stage of natural products drug discovery 
research [24]. By virtue of the plasmids present in them are 
known as highest producer of bioactive molecules. Many 
Streptomyces carry detectable extra chromosomal elements 
(plasmid) and in most cases, plasmid are present abundance 
in the form of covalently closed circular- DNA, but occasionally, 
linear elements are also found[25]. 
Most of the antibiotics are specific in their activity, some 
antibiotics are antagonistic to few bacteria only while other act 
against fungi. They are called as narrow spectrum antibiotic. 
Broad spectrum antibiotics repress the growth of both Gram 
positive and Gram negative bacteria. While certain other 
antibiotics are able to inhibit the growth of both bacteria and 
fungi or they are active against more than one microorganism 
[26]. 
Nowadays, antibiotic resistant pathogens pose an 
enormous threat in the treatment of infectious diseases. 
Appearance of antibiotic resistance in bacteria causes 
reduction in effectiveness of drugs in curing disease or 
improving a patient's symptoms. Since spread of antibiotic 
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resistance in microorganisms is very fast and exponential. 
Thus to prevent this exponential emergence of antibiotic 
resistance, a periodic replacement of the existing antibiotic with 
new and broad spectrum antibiotics is necessary [27]. 
Development of novel drugs having broad spectrum mode of 
action against drug resistant pathogen, is the need of an hour. 
Present study focused on the production of a broad spectrum 
antibiotic from Streptomyces VRY-1, which was found to be 
active against a drug resistant strain of bacteria Salmonella 
typhimurium ( MTCC 3214). S. typhimurium causes a food 
borne disease salmenellosis. Multidrug resistant (MDR) strain 
of it are now encountered frequently and the rates of multidrug 
resistance have increased considerably in recent years. The 
emergence of MDR in Salmonella strains with resistance to 
Fluroquinolones and third generation Cephalosporin is a 
serious problem, which results in severe limitation of the 
possibilities for effective treatment of human infections. 
Waksman and Lechevalier [20] advised to have an idea of 
the stability of the antibiotic substance at various temperatures 
and at various pH values before attempting to devise a method 
of their extraction. So, the optimization of cultural conditions for 
the production of antibiotic from Streptomyces VRY-1 was 
done. Production of antibiotic by Streptomyces VRY-1 
occurred at wide range of temperature, pH, glucose 
concentration, nitrogen source. This clearly indicates that the 
organism is producing a bioactive compound under different 
environmental conditions. The Streptomyces VRY-1 strain was 
found to produce a highly active antibiotic substance was 
tentatively identified as Streptomyces sp. based on their 
cultural characteristics, morphological, and its cell wall amino 
acid composition determination.  The isolate was also found to 
contain a plasmid which might be responsible for the 
production of bioactive compounds by it.  In order to reach the 
targeted area the antibiotic must be soluble in body fluids i.e., 
blood and lymph. Both of them contain large volume of water. 
Antibiotic substance produced by Streptomyces VRY-1 was 
found to be soluble in water and ethyl acetate but was not 
soluble in any other pure organic solvents tested, indicating its 
water solubiling nature.   
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